The critical early proinflammatory events associated with idiopathic pneumonia syndrome in irradiated murine allogeneic recipients are due to donor T cell infusion and potentiated by cyclophosphamide

Journal of Clinical Investigation

Volumn 100, Issue 5, 1997, Pages 1015-1027

  Panoskaltsis Mortari, Angela ^a   Taylor, Patricia A ^a   Yaeger, Thomas M ^a   Wangensteen, O Douglas ^b   Bitterman, Peter B ^b   Ingbar, David H ^b   Vallera, Daniel A ^b   Blazar, Bruce R ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Bone marrow transplant; Costimulatory molecules; Cytokines; Lung injury; Macrophages

Indexed keywords

CYCLOPHOSPHAMIDE;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; IDIOPATHIC DISEASE; INFLAMMATION; LUNG COMPLIANCE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; T LYMPHOCYTE; WHOLE BODY RADIATION;

EID: 0030982518     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119612     Document Type: Article

References (62)

1. Clark, J.G., J.A. Hansen, M.I. Hertz, R. Parkman, L. Jensen, and H.H. Peavy. 1993. Idiopathic pneumonia syndrome after bone marrow transplantation. Am. Rev. Respir. Dis. 147:1601-1606.
2. Weiner, R.S., M.M. Bortin, R.P. Gale, E. Gluckmann, H.E.M. Kay, J.H. Kolb, A.J. Hartz, and A.A. Rimm. 1986. Interstitial pneumonitis after bone marrow transplantation: assessment of risk factors. Ann. Intern. Med. 104:168-175.
3. Clift, R.A., C.D. Buckner, F.R. Appelbaum, S.I. Bearman, F.B. Petersen, L.B. Fisher, C. Anasetti, P. Beatty, W.I. Bensinger, K. Doney, et al. 1990. Allogeneic marrow transplantation in patients with acute leukemia in first remission: a randomized trial of two irradiation regimens. Blood. 76:1867-1871.
4. Petersen, F.B., H.J. Deeg, C.D. Buckner, F.R. Appelbaum, R. Storb, R.A. Clift, J.E. Sanders, W.I. Bensinger, R.P. Witherspoon, M. Sullivan, et al. 1992. Marrow transplantation following escalating doses of fractionated total body irradiation and cyclophosphamide: a phase I study. Int. J. Radiat. Oncol. Biol. Phys. 23:1027-1032.
5. Soderling, C.C.B., C.W. Song, B.R. Blazar, and D.A. Vallera. 1985. A correlation between conditioning and engraftment in recipients of MHC-mismatched T cell-depleted murine bone marrow transplants. J. Immunol. 135: 941-946.
6. Down, J.D., P. Mauch, M. Warhol, S. Neben, and J.L.M. Ferrara. 1992. The effect of donor T lymphocytes and total-body irradiation on hemopoietic engraftment and pulmonary toxicity following experimental allogeneic bone marrow transplantation. Transplantation (Baltimore). 54:802-808.
7. Gassmann, W., L. Uharek, H.-U. Wottge, N. Schmitz, H. Loffler, and W. Mueller-Ruchholtz. 1988. Comparison of cyclophosphamide, cytarabine, and etoposide as immunosuppressive agents before allogeneic bone marrow transplantation. Blood. 72:1574-1579.
8. Workman, D.L., and J. Clancy, Jr. 1994. Interstitial pneumonitis and lymphocytic bronchiolitis/bronchitis as a direct result of acute lethal graft-versus-host disease duplicate the histopathology of lung allograft rejection. Transplantation (Baltimore). 58:207-213.
9. Piguet, P.F., G.E. Grau, M.A. Collart, P. Vassalli, and Y. Kapanci. 1989. Pneumopathies of the graft-versus-host reaction. Alveolitis associated with an increased level of tumor necrosis factor mRNA and chronic interstitial pneumonitis. Lab. Invest. 61:37-45.
10. Holler, E., H.J. Kolb, J. Kempeni, S. Liesenfeld, H. Pechumer, W. Lehmacher, G. Ruckdeschel, B. Gleixner, C. Riedner, G. Ledderose, et al. 1990. Increased serum levels of tumor necrosis factor-α precede major complications of bone marrow transplantation. Blood. 75:1011-1016.
11. Xing, Z., M. Jordana, H. Kirpalani, K.E. Driscoll, T.J. Schall, and J. Gauldie. 1994. Cytokine expression by neutrophils and macrophages in vivo: endotoxin induces tumor necrosis factor-α, macrophage inflammatory protein-2, interleukin-1β, and interleukin-6 but not RANTES or transforming growth factor-β mRNA expression in acute lung inflammation. Am. J. Respir. Cell Mol. Biol. 10:148-153.
12. Ulich, T.R., E.S. Yi, S. Yin, C. Smith, and D. Remick. 1994. Intratracheal administration of endotoxin and cytokines. VII. The soluble interleukin-1 receptor and the soluble tumor necrosis factor receptor II (p80) inhibit acute inflammation. Clin. Immunol. Immunopathol. 72:137-140.
13. Ulich, T.R., S. Yin, D.G. Remick, D. Russell, S.P. Eisenberg, and T. Kohno. 1993. Intratracheal administration of endotoxin and cytokines. IV. The soluble tumor necrosis factor receptor type I inhibits acute inflammation. Am. J. Pathol. 142:1335-1338.
14. Cooke, K.R., L. Kobzik, T.R. Martin, J. Brewer, J. Delmonte, Jr., J.M. Crawford, and J.L.M. Ferrara. 1996. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation. I. The roles of minor H antigens and endotoxin. Blood. 88:3230-3239.
15. Haschek, W.M., and H. Witschi. 1979. Pulmonary fibrosis - a possible mechanism. Toxicol. Appl. Pharmacol. 51:475-487.
16. Haschek, W.M., A.J.P. Klein-Szanto, J.A. Last, K.M. Reiser, and H. Witschi. 1982. Long-term morphologic and biochemical features of experimentally induced lung fibrosis in the mouse. Lab. Invest. 46:438-449.
17. Fausto, N. 1991. Multifunctional roles for transforming growth factor-beta-1. Lab. Invest. 63:497-499.
18. Raghow, R. 1991. Role of transforming growth factor-beta in repair and fibrosis. Chest. 99:S61-S65.
19. Hoyt, D.G., and J.S. Lazo. 1989. Early increases in pulmonary mRNA encoding procollagens and transforming growth factor-β in mice sensitive to cyclophosphamide-induced pulmonary fibrosis. J. Pharmacol. Exp. Ther. 249:38-43.
20. Bentzen, S.M., J.Z. Skoczylas, M. Overgaard, and J. Overgaard. 1996. Radiotherapy-related lung fibrosis enhanced by tamoxifen. J. Natl. Cancer Inst. 88:918-922.
21. Broekelmann, T.J., A.H. Limper, T.V. Colby, and J.A. McDonald. 1991. Transforming growth factor β1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc. Natl. Acad. Sci. USA. 88:6642-6646.
22. Khalil, N., R.N. O'Connor, H.W. Unruh, P.W. Warren, K.C. Flanders, A. Kemp, O.H. Bereznay, and A.H. Greenberg. 1991. Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 5:155-162.
23. Fine, A., and R.H. Goldstein. 1987. The effect of transforming growth factor-β on cell proliferation and collagen formation by lung fibroblasts. J. Biol. Chem. 262:3897-3902.
24. Kelley, J., E.J. Kovacs, K. Nicholson, J.P. Fabisiak. 1991. Transforming growth factor-β production by lung macrophages and fibroblasts. Chest. 99 (Suppl.):85S-86S.
25. Dusenbery, K.E., K.A. Daniels, J.S. McClure, P.B. McGlave, N.K.C. Ramsay, B.R. Blazar, J.P. Neglia, J.H. Kersey, and W.G. Woods. 1995. Randomized comparison of cyclophosphamide-total body irradiation vs. busulfancyclophosphamide conditioning in autologous bone marrow transplantation for acute myeloid leukemia. Int. J. Radiat. Oncol. Biol. Phys. 31:119-128.
26. Blazar, B.R., P.A. Taylor, D.C. Snover, J.A. Bluestone, and D.A. Vallera. 1993. Nonmitogenic anti-CD3F(ab′)2 fragments inhibit lethal murine graft-versus-host disease induced across the major histocompatibility barrier. J. Immunol. 150:265-277.
27. Blazar, B.R., P.A. Taylor, P.S. Linsley, and D.A. Vallera. 1994. In vivo blockade of CD28/CTLA4:B7/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex (MHC) barrier in mice. Blood. 83:3815-3825.
28. Wangensteen, D., R. Piper, J.A. Johnson, A.A. Sinha, and D. Niewoehner. 1986. Solute conductance of blood-gas barrier in hamsters exposed to hyperoxia. J. Appl. Physiol. 60:1908-1916.
29. Berg, R.A. 1982. Determination of 3-and 4-hydroxyproline. Methods Enzymol. 82:372-398.
30. Wangensteen, D., R. Yankovich, J. Hoidal, and D. Niewoehner. 1983. Bleomycin-induced changes in pulmonary microvascular albumin permeability and extravascular albumin space. Am. Rev. Respir. Dis. 127:204-208.
31. Bachofen, H., J. Hildebrandt, and M. Bachofen. 1970. Pressure-volume curves of air-and liquid-filled excised lungs-surface tension in situ. J. Appl. Physiol. 29:422-431.
32. Blazar, B.R., P.A. Taylor, A. Panoskaltsis-Mortari, G.S. Gray, and D.A. Vallera. 1995. Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts. Blood. 85:2607-2618.
33. Panoskaltsis-Mortari, A., and R.P. Bucy. 1995. In situ hybridization with digoxigenin-labeled RNA probes: facts and artifacts. Biotechniques. 18:300-308.
34. Mantel, N. 1966. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep. 50:163-170.
35. Ashcroft, T., J.M. Simpson, and V. Timbrell. 1988. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J. Clin. Pathol. (Lond.). 41:467-470.
36. Yousem, S.A., G.J. Berry, E.M. Brunt, D. Chamberlain, R.H. Hruban, R.K. Sibley, S. Stewart, and H.D. Tazelaar. 1990. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: lung rejection study group. J. Heart Transplant. 9:593-601.
37. Pearson, A.E., and T.A. Phelps. 1981. Radiation effects on mouse incisor teeth following whole-body doses of up to 16 Gray. Int. J. Radiat. Biol. 39: 409-417.
38. Down, J.D., N.J. Tarbell, M. Warhol, and P. Mauch. 1988. Dose-limiting complications from upper half body irradiation in C3H mice. Int. J. Radiat. Oncol. Biol. Phys. 14:483-489.
39. Goad, M.E.P., A.F. Tryka, and H.P. Witschi. 1987. Acute respiratory failure induced by bleomycin and hyperoxia: pulmonary edema, cell kinetics and morphology. Toxicol. Appl. Pharmacol. 90:10-22.
40. Bitterman, P.B., L.E. Saltzman, S. Adelberg, V.J. Ferrans, and R.G. Crystal. 1984. Alveolar macrophage replication. One mechanism for the expansion of the mononuclear phagocyte population in the chronically inflamed lung. J. Clin. Invest. 74:460-469.
41. Shami, S.G., M.J. Evans, and L.A. Martinez. 1986. Type II cell proliferation related to migration of inflammatory cells into the lung. Exp. Mol. Pathol. 44:344-352.
42. Curtis, J.L., P.K. Byrd, M.L. Warnock, and H.B. Kaltreider. 1991. Requirement of CD4-positive T cells for cellular recruitment to the lungs of mice in response to a particulate intratracheal antigen. J. Clin. Invest. 88:1244-1254.
43. Braciak, T.A., K. Bacon, Z. Xing, D.J. Torry, F.L. Graham, T.J. Schall, C.D. Richards, K. Croitoru, and J. Gauldie. 1996. Overexpression of RANTES using a recombinant adenovirus vector induces the tissue-directed recruitment of monocytes to the lung. J. Immunol. 157:5076-5084.
44. Wahl, S.M., D.A. Hunt, L.M. Wakefield, N. McCartney-Francis, L.M. Wahl, A.B. Roberts, and M.B. Sporn. 1987. Transforming growth factor type β induces monocyte chemotaxis and growth factor production. Proc. Natl. Acad. Sci. USA. 84:5788-5792.
45. Postlethwaite, A.E., J. Keski-Oja, H.L. Moses, and A.H. Kang. 1987. Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor β. J. Exp. Med. 165:251-256.
46. Roberts, A.B., and M.B. Sporn. 1990. The transforming growth factor βs. In Peptide Growth Factors and their Receptors. M.B. Sporn and A.B. Roberts, editors, Springer-Verlag, Heidelberg. 419-172.
47. Cooper, J.A.D., Jr., W.W. Merrill, and H.Y. Reynolds. 1986. Cyclophosphamide modulation of bronchoalveolar cellular populations and macrophage oxidative metabolism. Am. Rev. Respir. Dis. 134:108-114.
48. Pelton, R.W., M.D. Johnson, E.A. Perkett, L.I. Gold, and H.L. Moses. 1991. Expression of transforming growth factor-β1, -β2, -β3 mRNA and protein in the murine lung. Am. J. Respir. Cell. Mol. Biol. 5:522-530.
49. Corrin, B., D. Butcher, B.J. McAnulty, R.M. Dubois, C.M. Black, G.J. Laurent, and N.K. Harrison. 1994. Immunohistochemical localization of transforming growth factor-β1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disorders. Histopathology (Oxf.). 24: 145-150.
50. Zugmaier, G., S. Paik, G. Wilding, C. Knabbe, M. Bano, R. Lupu, B. Deschauer, S. Simpson, R.B. Dickson, and M. Lippman. 1991. Transforming growth factor-β1 induces cachexia and systemic fibrosis without an antitumor effect in nude mice. Cancer Res. 51:3590-3594.
51. Anscher, M.S., W.P. Peters, H. Reisenbichler, W.P. Petros, and R.L. Jirtle. 1993. Transforming growth factor β as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced cancer. N. Engl. J. Med. 328:1592-1598.
52. Murase, T., M.S. Anscher, W.P. Petros, W.P. Peters, and R.L. Jirtle. 1995. Changes in plasma transforming growth factor β in response to high-dose chemotherapy for stage II breast cancer: possible implications for the prevention of hepatic veno-occlusive disease and pulmonary drug toxicity. Bone Marrow Transplant. 15:173-178.
53. Nagelkerken, L., K.J. Collob, M. Tielemans, and R.L. Coffman. 1993. Role of transforming growth factor-β in the preferential induction of T helper cells of type 1 staphylococcal enterotoxin B. Eur. J. Immunol. 23:2306-2310.
54. Elias, J.A., B. Freundlich, J.A. Kern, and J. Rosenhloom. 1990. Cytokine networks in the regulation of inflammation and fibrosis in the lung. Chest. 97:1439-1445.
55. Xun, C.Q., J.S. Thompson, C.D. Jennings, S.A. Brown, and M.B. Widmer. 1994. Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2 incompatible transplanted scid mice. Blood. 83:2360-2367.
56. Down, J.D., D. Nicholas, and G.G. Steel. 1986. Lung damage after hemithoracic irradiation: dependence on mouse strain. Radiother. Oncol. 6:43-50.
57. Kallenberg, C.G.M., B.M. Schilizzi, F. Beaumont, L.D.E. Leij, S. Poppema, and T.H. The. 1987. Expression of class II major histocompatibility complex antigens on alveolar epithelium in interstitial lung disease: relevance to pathogenesis of idiopathic pulmonary fibrosis. J. Clin. Pathol. (Lond.). 40: 725-733.
58. Komatsu, T., M. Yamamoto, K. Shimokata, and H. Nagura. 1989. Phenotypic characterization of alveolar capillary endothelial cells, alveolar epithelial cells and alveolar macrophages in patients with pulmonary fibrosis, with special reference to MHC class II antigens. Virchows Archiv. Abt. Pathol. Anat. 415:79-90.
59. June, C.H., J.A. Bluestone, L.M. Nadler, and C.B. Thompson. 1994. The B7 and CD28 receptor families. Immunol. Today. 15:321-331.
60. Schwartz, R.H. 1992. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell. 71: 1065-1068.
61. + T cells. J. Immunol. 157:3250-3259.
62. Morse, C.C., C. Sigler, S. Lock, P.J. Hakkinen, W.M. Haschek, and H.P. Witschi. 1985. Pulmonary toxicity of cyclophosphamide: a 1-year study. Exp. Mol. Pathol. 42:251-260.